Literature DB >> 17574096

Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

Haileyesus Getahun1, Mark Harrington2, Rick O'Brien3, Paul Nunn4.   

Abstract

The HIV epidemic has led to large increases in the frequency of smear-negative pulmonary tuberculosis, which has poor treatment outcomes and excessive early mortality compared with smear-positive disease. We used a combination of systematic review, document analysis, and global expert opinion to review the extent of this problem. We also looked at policies of national tuberculosis control programmes for the diagnosis of smear-negative pulmonary tuberculosis to assess their coverage, identify the diagnostic difficulties, and find ways to improve the diagnosis of this type of tuberculosis, with a focus on resource-constrained settings with high HIV infection rates. We propose that the internationally recommended algorithm for the diagnosis of smear-negative pulmonary tuberculosis should be revised to include HIV status, severity of AIDS and tuberculosis, and early use of chest radiography in the decision tree. Increased use of promising methods of diagnosis such as sputum liquefaction and concentration and increased availability of fluorescence microscopy should be explored and encouraged. Culturing of sputum in resource-constrained settings with high HIV infection rates should also be encouraged, existing facilities should be made full use of and upgraded, and effective quality-assurance systems should be used. Innovative ways to address human resources issues involved in addressing the diagnostic difficulties are also needed. The development of rapid, simple, and accurate tuberculosis diagnostic tools with applicability at point of care and remote location is essential. To achieve these goals, greater political commitment, scientific interest, and investment are needed.

Entities:  

Mesh:

Year:  2007        PMID: 17574096     DOI: 10.1016/S0140-6736(07)60284-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  236 in total

1.  Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis.

Authors:  Maunank Shah; Neil A Martinson; Richard E Chaisson; Desmond J Martin; Ebrahim Variava; Susan E Dorman
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

Review 2.  Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis.

Authors:  L L Flores; K R Steingart; N Dendukuri; I Schiller; J Minion; M Pai; A Ramsay; M Henry; S Laal
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

3.  Impact of a training course on the quality of chest radiography to diagnose pulmonary tuberculosis.

Authors:  A Ohkado; P Luna; A Querri; M Mercader; S Yoshimatsu; L Coprada; R Bañares; A M C Garfin; T Date
Journal:  Public Health Action       Date:  2015-03-21

4.  Documentation and treatment outcomes of smear-negative and extra-pulmonary tuberculosis in Ethiopia.

Authors:  F Tesgaye; A Defar; T Beyene; O Shafi; E Klinkenberg; R Howe
Journal:  Public Health Action       Date:  2014-12-21

5.  Improved Diagnosis of Pulmonary Tuberculosis using bleach Microscopy Method.

Authors:  Preeti B Mindolli; Manjunath P Salmani; Prashant K Parandekar
Journal:  J Clin Diagn Res       Date:  2013-07-01

6.  Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa.

Authors:  Karen R Jacobson; Danie Theron; Emily A Kendall; Molly F Franke; Marinus Barnard; Paul D van Helden; Tommie C Victor; Elizabeth M Streicher; Megan B Murray; Robin M Warren
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

7.  Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis.

Authors:  Edward Jones-López; Yukari C Manabe; Moises Palaci; Carol Kayiza; Derek Armstrong; Lydia Nakiyingi; Willy Ssengooba; Mary Gaeddert; Rachel Kubiak; Pedro Almeida Júnior; David Alland; Reynaldo Dietze; Moses Joloba; Jerrold J Ellner; Susan E Dorman
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

8.  Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.

Authors:  Anne F Luetkemeyer; Michelle A Kendall; Xingye Wu; Maria Cristina Lourenço; Ute Jentsch; Susan Swindells; Sarojini S Qasba; Jorge Sanchez; Diane V Havlir; Beatriz Grinsztejn; Ian M Sanne; Cynthia Firnhaber
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

9.  Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV.

Authors:  R Dawson; P Masuka; D J Edwards; E D Bateman; L-G Bekker; R Wood; S D Lawn
Journal:  Int J Tuberc Lung Dis       Date:  2010-01       Impact factor: 2.373

10.  Early mortality and cause of deaths in patients using HAART in Brazil and the United States.

Authors:  Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.